Showing results (381-390 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|November 3, 1997
Reassessing quality-of-life instruments in the evaluation of new drugsG H Guyatt, R J JaeschkePharmacoeconomics|November 3, 1997
Costs of treating dystonias and hemifacial spasm with botulinum toxin AR C Dodel, A Kirchner, R Koehne-Volland, et al.Pharmacoeconomics|December 8, 1997
Cost implications of initial antidepressant selection in primary careG E Simon, P FishmanPharmacoeconomics|December 8, 1997
Single European currency and Monetary Union. Macroeconomic implications for pharmaceutical spendingP KanavosPharmacoeconomics|December 8, 1997
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infectionsG L Plosker, R H Foster, P BenfieldPharmacoeconomics|December 8, 1997
Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritisF Fagnani, G Bouvenot, J P Valat, et al.Pharmacoeconomics|June 6, 1998
A new product pricing model using intracorporate market perceptions to extract the value of additional informationR S Woodward, L Amir, M A Schnitzler, et al.Pharmacoeconomics|April 7, 1998
The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed dataA Desgagné, A M Castilloux, J F Angers, et al.Pharmacoeconomics|April 7, 1998
Linking the health utilities index to National Medical Expenditure Survey dataJ A Rizzo, S Pashko, R Friedkin, et al.Pharmacoeconomics|September 4, 1996
Sertraline. A pharmacoeconomic evaluation of its use in depressionR Davis, M I WildePageof 335